Stem cells in the diabetic infarcted heart

Carley E Glass1, Pawan K Singal, Dinender K Singla

  • 1Biomolecular Science Center, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, 4000 Central Florida BLVD, Room 224, Orlando, FL 32816, USA.

Heart Failure Reviews
|June 19, 2010
PubMed

Insights

Diabetic heart disease is complex. This review explores stem cell therapy

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Diabetology

Background:

  • Diabetes mellitus is a leading cause of mortality, primarily due to cardiovascular diseases.
  • Diabetic patients experience more complex myocardial infarction progression and heart failure.
  • Current treatments for diabetic heart failure have limited efficacy, highlighting the need for novel approaches.

Purpose of the Study:

  • To review the pathogenesis of myocardial infarction in diabetic hearts.
  • To explore the potential of stem cell therapy for repairing and regenerating the diabetic infarcted heart.

Main Methods:

  • Literature review focusing on diabetic cardiomyopathy and stem cell therapy research.
  • Analysis of existing studies on stem cell transplantation in diabetic animal models.
  • Discussion of the mechanisms underlying stem cell-mediated cardiac repair.

Main Results:

  • Diabetic hearts exhibit unique pathological changes that complicate recovery after infarction.
  • Limited but emerging data suggests potential benefits of stem cell therapy in diabetic models.
  • Further research is needed to optimize stem cell types and delivery for diabetic heart repair.

Conclusions:

  • Stem cell therapy holds promise as a therapeutic strategy for diabetic heart disease.
  • Understanding the specific challenges in diabetic hearts is crucial for effective cell therapy.
  • More extensive studies in diabetic models are required to validate stem cell therapy's efficacy and safety.

Related Concept Videos